bebtelovimab (LY-CoV1404) - AbCellera, Eli Lilly
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
Lagevrio (molnupiravir) - Ridgeback Biotherap, Merck (MSD)
Xevudy (sotrovimab) - GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases
http://www.ncbi.nlm.nih.gov/pubmed/39293594
 
Maik Kschischo; Matthias Dobbelstein; Priya Kumar; Rahul Shaha; Xiaoxiao Zhang
 
Sep 21, 2024
 
Prev Next